Thomas Shrader
Stock Analyst at BTIG
Total Price Targets
10
Stocks Covered
9
Sectors
Healthcare
Most Recent
Mar 18, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Thomas Shrader
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| HROW | Harrow Health, Inc. | $63.00 | $41.27 | +52.7% | 1 | Mar 18, 2026 |
| ANRO | Alto Neuroscience, Inc. | $28.00 | $24.73 | +13.2% | 1 | Feb 17, 2026 |
| IRD | Opus Genetics, Inc. | $7.00 | $5.17 | +35.5% | 1 | Jan 20, 2026 |
| STOK | Stoke Therapeutics, Inc. | $28.00 | $33.22 | -15.7% | 1 | Aug 18, 2025 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $48.00 | $8.64 | +455.2% | 1 | Mar 10, 2025 |
| DNLI | Denali Therapeutics Inc. | $32.00 | $18.49 | +73.1% | 2 | Jan 7, 2025 |
| BHVN | Biohaven Ltd. | $59.00 | $9.71 | +507.6% | 1 | Sep 23, 2024 |
| OVID | Ovid Therapeutics Inc. | $11.00 | $2.79 | +293.6% | 1 | May 20, 2024 |
| GANX | Gain Therapeutics, Inc. | $10.00 | $1.90 | +426.3% | 1 | Nov 13, 2022 |
Recent Activity
- Mar 18, 2026— Set$63.00price target onHROW(Harrow Health, Inc.)
- Feb 17, 2026— Set$28.00price target onANRO(Alto Neuroscience, Inc.)
- Jan 20, 2026— Set$7.00price target onIRD(Opus Genetics, Inc.)
- Aug 18, 2025— Set$28.00price target onSTOK(Stoke Therapeutics, Inc.)
- Mar 10, 2025— Set$48.00price target onARCT(Arcturus Therapeutics Holdings Inc.)
- Jan 7, 2025— Set$32.00price target onDNLI(Denali Therapeutics Inc.)
- Oct 14, 2024— Set$35.00price target onDNLI(Denali Therapeutics Inc.)
- Sep 23, 2024— Set$59.00price target onBHVN(Biohaven Ltd.)
- May 20, 2024— Set$11.00price target onOVID(Ovid Therapeutics Inc.)
- Nov 13, 2022— Set$10.00price target onGANX(Gain Therapeutics, Inc.)
Frequently Asked Questions
Who is Thomas Shrader?
Thomas Shrader is a stock analyst at BTIG covering 9 stocks primarily in Healthcare. They have issued 10 price targets since Nov 13, 2022.
What stocks does Thomas Shrader cover?
Thomas Shrader currently covers 9 stocks, including DNLI, HROW, ANRO, IRD, STOK.
What is Thomas Shrader's latest price target?
Thomas Shrader's most recent price target was $63.00 on HROW (Harrow Health, Inc.), set on Mar 18, 2026.
What is Thomas Shrader's highest price target?
Thomas Shrader's highest issued price target is $63.00 on HROW, set on Mar 18, 2026.
More Analysts at BTIG
Coverage based on publicly published price targets. Not investment advice.